These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1925514)

  • 21. Insertion of prolonged venous access device: a comparison between surgical cutdown and percutaneous techniques.
    Sarzo G; Finco C; Parise P; Savastano S; Vecchiato M; Degregori S; Merigliano S
    Chir Ital; 2004; 56(3):437-42. PubMed ID: 15287644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of in-dwelling venous access devices: a single institution experience.
    Burney IA; Khurshaidi N; Akbar MT; Bhatti FN; Siddiqui T; Sophie Z
    J Pak Med Assoc; 2001 Dec; 51(12):434-7. PubMed ID: 11850980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk related to implant sites in home infusion therapy].
    Laumond R
    Soins; 2001 Nov; (660):46-8. PubMed ID: 12013000
    [No Abstract]   [Full Text] [Related]  

  • 24. Totally implantable central venous access devices in pediatric oncology--our experience in 46 patients.
    De Backer A; Vanhulle A; Otten J; Deconinck P
    Eur J Pediatr Surg; 1993 Apr; 3(2):101-6. PubMed ID: 8323914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive power Doppler-mediated diagnosis of catheter leakage in a totally implanted venous access port.
    Brücher BL; Stock K; Weiss W; Ungeheuer A; Erdmann J; Lersch C
    J Ultrasound Med; 2005 Jan; 24(1):109-11. PubMed ID: 15615936
    [No Abstract]   [Full Text] [Related]  

  • 26. Complications associated with venous access devices: Part two.
    Hamilton H
    Nurs Stand; 2006 Mar 15-21; 20(27):59-65; quiz 66. PubMed ID: 16566340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Completely implantable venous access systems. A study of the morbidity and benefits of a model third-generation device, the PAS Port with Cath-Finder].
    Miguelena Bobadilla JM; Sousa Domínguez R; Güemes Sánchez A; Cabezali Sánchez R; Gil Romea I; Palacín García-Valiño R; Burdio Pinilla F
    Nutr Hosp; 1995; 10(2):99-103. PubMed ID: 7756397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extravasation of cytostatics. Example of a severe complication from the use of long-term central venous catheters].
    Bach F; Videbaek C; Holst-Christensen J; Boesby S
    Ugeskr Laeger; 1991 Oct; 153(41):2896-7. PubMed ID: 1949309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The complications of central venous access systems: a study of 218 patients.
    Torramadé JR; Cienfuegos JA; Hernández JL; Pardo F; Benito C; González J; Balén E; de Villa V
    Eur J Surg; 1993; 159(6-7):323-7. PubMed ID: 8104491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an implantable venous access system in a general oncology population.
    Barrios CH; Zuke JE; Blaes B; Hirsch JD; Lyss AP
    Oncology; 1992; 49(6):474-8. PubMed ID: 1465287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications in connection with venous port systems: prevention and therapy.
    Rauthe G; Altmann C
    Eur J Surg Oncol; 1998 Jun; 24(3):192-9. PubMed ID: 9630859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experiences with the Port-A-Cath system in children].
    Wildhaber B; Kistler W; Caflisch U
    Schweiz Med Wochenschr; 2000 May; 130(20):732-8. PubMed ID: 10920850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a polymer implanted port access device.
    Brown JM
    J Intraven Nurs; 1996; 19(6):303-6. PubMed ID: 9060356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complications of central venous and indwelling catheterization].
    Douard MC; Desruennes E; Kriegel I; Blot F
    Rev Prat; 2006 Jun; 56(12):1281-9. PubMed ID: 16948214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with an implantable venous access system for chemotherapy.
    Pettengell R; Davies AJ; Harvey VJ
    N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of implanted venous port-a-caths in children with medical complexity and neurologic impairment.
    Pezeshkpour P; Armstrong NC; Mahant S; Muthusami P; Amaral JG; Parra DA; Temple MJ; Connolly BL
    Pediatr Radiol; 2019 Sep; 49(10):1354-1361. PubMed ID: 31302737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
    Haslik W; Hacker S; Felberbauer FX; Thallinger C; Bartsch R; Kornauth C; Deutschmann C; Mader RM
    Eur J Surg Oncol; 2015 Mar; 41(3):378-85. PubMed ID: 25515823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicant extravasation from an implanted venous access port.
    Wickham R
    Oncology (Williston Park); 2009 Apr; 23(4 Suppl Nurse Ed):34-8. PubMed ID: 19856596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.